Characterization of ex vivo expanded natural killer cells for cancer immunotherapy
Immunology & Cell Biology · 2025-08 · 103 (7) · 664-682
DOI: 10.1111/imcb.70038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, online erschienen am 18.06.2025. Verfasst von Jin Young Min und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biopharmaceutical Research Center, Ochang Institute of Biological and Environmental Science, Korea Basic Science Institute (KBSI), Cheongju, South Ko…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Immunotherapy, Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Food Research Institute, National Research Foundation of Korea (NRF), National Research Council for Science and Technology (NST).
Abstract (Originalsprache)
In this study, we employed a coculture system to expand natural killer (NK) cells ex vivo from healthy donors and patients with breast cancer and investigated their surface marker expression. We further analyzed the activation markers of primary expanded NK cells on Day 13 using cytokine arrays and dimensionality reduction techniques. Cytokine profiles were observed on Days 0, 6 and 13 (TS ‐ NK). To validate the anticancer activity of the expanded NK cells, we conducted lactate dehydrogenase assays against the hematologic cancer cell line K562 using cells from 10 donors (five patients with cancer and five healthy individuals). Additionally, we examined the antibody‐dependent cellular cytotoxicity (ADCC) of differentiated NK cells cocultured with SK‐BR‐3 cells in the presence of the HER2‐targeting monoclonal antibodies, trastuzumab and pertuzumab. Our findings demonstrate the stable expansion of NK cells from donor peripheral blood mononuclear cells and their potent anticancer effects and ADCC against both hematologic and solid tumors, highlighting their potential as a versatile therapeutic approach in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biopharmaceutical Research Center, Ochang Institute of Biological and Environmental Science, Korea Basic Science Institute (KBSI), Cheongju, South Korea.
- TSBIO ALL Co., Ltd, Seoul, South Korea.
- Korea University of Science and Technology (UST), Daejeon, South Korea.
- College of Medicine, Inha University, Incheon, Republic of Korea.
ORCID-Profile: Eun Hee Han
Förderung
- Korea Food Research Institute
- National Research Foundation of Korea (NRF)
- National Research Council for Science and Technology (NST)
- Korea Basic Science Institute
- Ministry of Science and ICT (Republic of Korea)
- TS Bio Co
- National Research Council of Science and Technology
Zitieren
APA
Min, J. Y., Ko, T. K., Kim, H. M., Jung, H. W., Yim, C. O., & Han, E. H. (2025). Characterization of ex vivo expanded natural killer cells for cancer immunotherapy. Immunology & Cell Biology, 103(7), 664-682. https://doi.org/10.1111/imcb.70038
Vancouver
Min JY, Ko TK, Kim HM, Jung HW, Yim CO, Han EH. Characterization of ex vivo expanded natural killer cells for cancer immunotherapy. Immunology & Cell Biology. 2025;103(7):664-682. doi:10.1111/imcb.70038
BibTeX
@article{Min2025,
author = {Min, Jin Young and Ko, Tae Kyung and Kim, Hye Min and Jung, Hae Won and Yim, Cha Ok and Han, Eun Hee},
title = {Characterization of ex vivo expanded natural killer cells for cancer immunotherapy},
journal = {Immunology & Cell Biology},
year = {2025},
volume = {103},
number = {7},
pages = {664--682},
doi = {10.1111/imcb.70038}
}
EUVIMED